Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
50.6 PLN | +1.00% | -1.17% | -12.00% |
17/05 | Transcript : Ryvu Therapeutics S.A. - Special Call | |
13/03 | Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Small Molecule Therapies
100.0
%
| 39 | 100.0 % | 47 | 100.0 % | +20.32% |
Sales per region
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
European Union Countries
88.9
%
| 25 | 63.2 % | 42 | 88.9 % | +69.25% |
Other Countries
11.0
%
| 14 | 36.5 % | 5 | 11.0 % | -63.73% |
Poland
0.1
%
| 0 | 0.3 % | 0 | 0.1 % | -64.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01/07/01 | |
Hendrik Nogai
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Chief Operating Officer | 38 | 01/13/01 | |
Chief Tech/Sci/R&D Officer | - | 01/07/01 | |
Vatnak Vat-Ho
PRN | Corporate Officer/Principal | - | 26/21/26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | - | |
Scott Fields
BRD | Director/Board Member | 69 | 14/23/14 |
Thomas Turalski
BRD | Director/Board Member | - | - |
Rafal Chwast
BRD | Director/Board Member | - | - |
Piotr Romanowski
CHM | Chairman | - | 01/19/01 |
Director/Board Member | 64 | 01/19/01 | |
Peter Smith
BRD | Director/Board Member | - | 14/23/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,120,148 | 14,971,047 ( 64.75 %) | 317 ( 0.001371 %) | 64.75 % |
Company contact information
Sector
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.00% | 29Cr | |
+15.19% | 12TCr | |
+19.91% | 11TCr | |
-19.80% | 2.04TCr | |
-15.92% | 1.65TCr | |
-13.45% | 1.64TCr | |
-44.35% | 1.56TCr | |
+66.67% | 1.52TCr | |
+2.13% | 1.35TCr | |
+119.39% | 1.1TCr |
- Stock Market
- Equities
- RVU Stock
- Company Ryvu Therapeutics S.A.